Amplified Sciences has received CAP accreditation for its clinical laboratory, enabling broader commercial deployment of its PanCystPro assay for pancreatic cancer risk assessment, the company announced.
A new analysis finds that policy and payment gaps are limiting access to diagnostics, with nearly half the world lacking adequate testing and reimbursement lagging behind advances in precision therapies.
Biotia’s clinical study, published in Microbiology Spectrum, validates an NGS and machine learning assay for UTIs, reporting 97.2% sensitivity and 99.6% specificity in direct detection and AMR profiling from urine samples.
NeoGenomics has integrated its oncology testing portfolio with Epic Aura, allowing physicians nationwide to order tests and view results within the Epic EHR system, aiming to streamline workflows and expand test adoption, according to the company.
A study identified microRNA patterns in blood plasma that could support noninvasive diagnosis and monitoring of the most aggressive form of brain cancer.
